These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

361 related articles for article (PubMed ID: 33285579)

  • 1. The History of Psychedelics in Psychiatry.
    Nichols DE; Walter H
    Pharmacopsychiatry; 2021 Jul; 54(4):151-166. PubMed ID: 33285579
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Psychosis and psychedelics: Historical entanglements and contemporary contrasts.
    Friesen P
    Transcult Psychiatry; 2022 Oct; 59(5):592-609. PubMed ID: 36300247
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Psychedelic Psychiatry: Preparing for Novel Treatments Involving Altered States of Consciousness.
    Holoyda B
    Psychiatr Serv; 2020 Dec; 71(12):1297-1299. PubMed ID: 33050796
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ethical and Practical Considerations for the Use of Psychedelics in Psychiatry.
    Barber GS; Dike CC
    Psychiatr Serv; 2023 Aug; 74(8):838-846. PubMed ID: 36987705
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Classical psychedelics in psychiatry - renaissance of interest and therapeutic perspectives.
    Jachimowski A; Kucia K
    Psychiatr Pol; 2023 Jun; 57(3):657-670. PubMed ID: 38043078
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Beyond LSD: A Broader Psychedelic Zeitgeist during the Early to Mid-20
    Aday JS; Bloesch EK; Davoli CC
    J Psychoactive Drugs; 2019; 51(3):210-217. PubMed ID: 30836890
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Using Psychedelics in Clinical Practice: Comparing Therapeutic Uses and Potential Harms.
    Tariq R
    Curr Rev Clin Exp Pharmacol; 2023; 18(2):94-109. PubMed ID: 35319407
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Psychedelics and mental health: a population study.
    Krebs TS; Johansen PØ
    PLoS One; 2013; 8(8):e63972. PubMed ID: 23976938
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Self-Entropic Broadening Theory: Toward a New Understanding of Self and Behavior Change Informed by Psychedelics and Psychosis.
    Dourron HM; Strauss C; Hendricks PS
    Pharmacol Rev; 2022 Oct; 74(4):982-1027. PubMed ID: 36113878
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Psychedelics and psychotherapy in Canada: Humphry Osmond and Aldous Huxley.
    Dyck E; Farrell P
    Hist Psychol; 2018 Aug; 21(3):240-253. PubMed ID: 30138029
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Classical Psychedelics as Therapeutics in Psychiatry - Current Clinical Evidence and Potential Therapeutic Mechanisms in Substance Use and Mood Disorders.
    Mertens LJ; Preller KH
    Pharmacopsychiatry; 2021 Jul; 54(4):176-190. PubMed ID: 33472250
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Psychiatry & the psychedelic drugs. Past, present & future.
    Rucker JJH; Iliff J; Nutt DJ
    Neuropharmacology; 2018 Nov; 142():200-218. PubMed ID: 29284138
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Psychedelic medicine at a crossroads: Advancing an integrative approach to research and practice.
    Gobbi G; Inserra A; Greenway KT; Lifshitz M; Kirmayer LJ
    Transcult Psychiatry; 2022 Oct; 59(5):718-724. PubMed ID: 36263521
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Why psychiatry needs psychedelics and psychedelics need psychiatry.
    Sessa B
    J Psychoactive Drugs; 2014; 46(1):57-62. PubMed ID: 24830186
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Classic psychedelics: An integrative review of epidemiology, therapeutics, mystical experience, and brain network function.
    Johnson MW; Hendricks PS; Barrett FS; Griffiths RR
    Pharmacol Ther; 2019 May; 197():83-102. PubMed ID: 30521880
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The neurobiology of psychedelic drugs: implications for the treatment of mood disorders.
    Vollenweider FX; Kometer M
    Nat Rev Neurosci; 2010 Sep; 11(9):642-51. PubMed ID: 20717121
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Psychedelics: Where we are now, why we got here, what we must do.
    Belouin SJ; Henningfield JE
    Neuropharmacology; 2018 Nov; 142():7-19. PubMed ID: 29476779
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Peak experiences and the afterglow phenomenon: when and how do therapeutic effects of hallucinogens depend on psychedelic experiences?
    Majić T; Schmidt TT; Gallinat J
    J Psychopharmacol; 2015 Mar; 29(3):241-53. PubMed ID: 25670401
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Psychedelic Drugs in Biomedicine.
    Kyzar EJ; Nichols CD; Gainetdinov RR; Nichols DE; Kalueff AV
    Trends Pharmacol Sci; 2017 Nov; 38(11):992-1005. PubMed ID: 28947075
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Shamans, sacraments, and psychiatrists.
    Bravo G; Grob C
    J Psychoactive Drugs; 1989; 21(1):123-8. PubMed ID: 2656948
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.